These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7686121)

  • 1. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease.
    Yokosuka O; Omata M; Ito Y; Ohto M
    Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.
    Mita E; Hayashi N; Ueda K; Kasahara A; Fusamoto H; Takamizawa A; Matsubara K; Okayama H; Kamada T
    Biochem Biophys Res Commun; 1992 Mar; 183(3):925-30. PubMed ID: 1314578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot.
    Yokosuka O; Ito Y; Sakuma J; Imazeki F; Ohto M; Omata M
    Dig Dis Sci; 1993 Apr; 38(4):626-30. PubMed ID: 7681745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of E2/NS1 protein of hepatitis C virus and detection of anti-E2/NS1 antibodies in chronic liver disease patients.
    Pandya J; Chakraborti A; Chawla Y
    J Biomed Sci; 2003; 10(2):276-82. PubMed ID: 12595764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
    Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
    Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
    Kobayashi M; Tanaka E; Matsumoto A; Ichijo T; Kiyosawa K
    J Gastroenterol Hepatol; 1997 Jan; 12(1):73-6. PubMed ID: 9076628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis.
    Yokosuka O; Ito Y; Ohto M; Omata M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():52-4. PubMed ID: 7689507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera.
    Khanna A; Ray R
    Gene; 1995 Feb; 153(2):185-9. PubMed ID: 7533115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
    Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
    J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
    Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
    J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease.
    Hada H; Koide N; Hanafusa T; Sakaguchi K; Shinji T; Sasaki S; Oka T; Takayama N; Yumoto Y; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):365-70. PubMed ID: 1279946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.